Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L David

Showing results (271-280 of 1,779) with videos related to

Pageof 178
Sort By:
JACC. Cardiovascular Interventions|September 24, 2011
The hazards of comparative effectiveness when we cannot effectively compareRichard A Lange, L David Hillis
Advances in Therapy|November 23, 2011
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsificationFrank A Bucci, L David Waterbury
Journal of Clinical Microbiology|March 1, 1977
beta-Glucosidase activity in mycobacteriaH L David, M T Jahan
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 1, 1996
[Bloody nipple discharge in infants and young children]D Phan, H N'Guyêt, L David
Communicable Diseases Intelligence Quarterly Report|November 20, 2014
Rotavirus gastroenteritis hospitalisations following introduction of vaccination, CanberraRosemary L David, Martyn D Kirk
Seminars in Perinatology|June 9, 2019
The role of the obstetrician in the prevention of retinopathy of prematurityLindsay M Kindinger, Anna L David
Clinical Endocrinology|June 1, 1977
Linear growth and pubertal development in treated congenital adrenal hyperplasia due to 21-hydroxylase deficiencyI Ghali, M David, L David
Lens and Eye Toxicity Research|January 1, 1989
Role of proteolysis in lenses: a reviewL L David, T R Shearer
Nature Reviews. Microbiology|October 17, 2012
Modulation of innate immunity by Toxoplasma gondii virulence effectorsChristopher A Hunter, L David Sibley
Placenta|March 31, 2015
Animal models of fetal growth restriction: Considerations for translational medicineA M Swanson, A L David
Pageof 178

Showing results (271-280 of 1,779) with videos related to

Sort By:
Pageof 178
JACC. Cardiovascular Interventions|September 24, 2011
The hazards of comparative effectiveness when we cannot effectively compareRichard A Lange, L David Hillis
Advances in Therapy|November 23, 2011
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsificationFrank A Bucci, L David Waterbury
Journal of Clinical Microbiology|March 1, 1977
beta-Glucosidase activity in mycobacteriaH L David, M T Jahan
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 1, 1996
[Bloody nipple discharge in infants and young children]D Phan, H N'Guyêt, L David
Communicable Diseases Intelligence Quarterly Report|November 20, 2014
Rotavirus gastroenteritis hospitalisations following introduction of vaccination, CanberraRosemary L David, Martyn D Kirk
Seminars in Perinatology|June 9, 2019
The role of the obstetrician in the prevention of retinopathy of prematurityLindsay M Kindinger, Anna L David
Clinical Endocrinology|June 1, 1977
Linear growth and pubertal development in treated congenital adrenal hyperplasia due to 21-hydroxylase deficiencyI Ghali, M David, L David
Lens and Eye Toxicity Research|January 1, 1989
Role of proteolysis in lenses: a reviewL L David, T R Shearer
Nature Reviews. Microbiology|October 17, 2012
Modulation of innate immunity by Toxoplasma gondii virulence effectorsChristopher A Hunter, L David Sibley
Placenta|March 31, 2015
Animal models of fetal growth restriction: Considerations for translational medicineA M Swanson, A L David
Pageof 178